These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 5535845)
1. [Studies on gravidic and fetal toxicity of alpha-6-deoxy-5-oxytetracycline (doxycycline) in mouse and rabbit]. Bastianini L; Felisati D Antibiotica; 1970; 8(2):161-78. PubMed ID: 5535845 [No Abstract] [Full Text] [Related]
3. The teratogenic effects in rabbits of doxycycline, dissolved in polyvinylpyrrolidone, injected into the yolk sac. Claussen U; Breuer HW Teratology; 1975 Dec; 12(3):297-301. PubMed ID: 1198337 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of doxycycline in the developmental age]. Bononi LJ; Ceccarelli G; Ciaffi G Boll Chim Farm; 1972 Nov; 111(11):700-8. PubMed ID: 4655673 [No Abstract] [Full Text] [Related]
5. The susceptibility of the offspring of alloxandiabetic mice to a teratogen. Takano K; Tanimura T; Nishimura H J Embryol Exp Morphol; 1965 Aug; 14(1):63-73. PubMed ID: 4956202 [No Abstract] [Full Text] [Related]
6. [Fetal abnormalities caused by treatment of the mother prior to the 5th day of pregnancy]. Nothdurft H Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):411-2. PubMed ID: 4253838 [No Abstract] [Full Text] [Related]
8. [Oxytetracycline penetration, distribution and retention in the body of pregnant rabbits and their fetuses]. Nurazian AG Zh Eksp Klin Med; 1976; 16(5):20-5. PubMed ID: 1023703 [No Abstract] [Full Text] [Related]
9. Different embryo-fetal toxicity effects for three VLA-4 antagonists. Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199 [TBL] [Abstract][Full Text] [Related]
10. Maternal toxicity--a possible factor in fetal malformations in mice. Khera KS Teratology; 1984 Jun; 29(3):411-6. PubMed ID: 6379969 [TBL] [Abstract][Full Text] [Related]
11. [Is there a relation between the teratogenic effect and transplacental passage of drugs?]. Cahen R; Fave A C R Seances Soc Biol Fil; 1970; 164(3):610-6. PubMed ID: 4250418 [No Abstract] [Full Text] [Related]
12. [Experimental studies of the effects of administration of fluorouracil in the early stages of pregnancy. I. Treatment of gravid rats with fluorouracil]. Lauro V; Giornelli C; Santilli Giornelli FE; Fanelli A Arch Ostet Ginecol; 1968 Apr; 73(2):227-37. PubMed ID: 5706084 [No Abstract] [Full Text] [Related]
14. The use of marmosets (Callithrix jacchus) in teratological and toxicological research. Siddall RA Primates Med; 1978; 10():215-24. PubMed ID: 417324 [No Abstract] [Full Text] [Related]
15. Effect of some nonspecific factors accompanying intraamniotic injection in mouse foetus. Dostál M Folia Morphol (Praha); 1973; 21(1):97-101. PubMed ID: 4734539 [No Abstract] [Full Text] [Related]
16. [The transplacental transit and action of ceftazidime on the fetus in an experiment on animals at different times of the pregnancy]. Kasabulatov NM; Sheveleva GA; Voropaeva SD Eksp Klin Farmakol; 1994; 57(5):29-32. PubMed ID: 7696899 [TBL] [Abstract][Full Text] [Related]
17. [Fetal damage by drugs in animal experiments (prenatal toxicology-a new branch of experimental research)]. von Kreybig T Hippokrates; 1969 Mar; 40(6):201-9. PubMed ID: 5802153 [No Abstract] [Full Text] [Related]
18. Fetal environment and its influence on fetal development. Shabanah EH; Tricomi V; Suarez JR Surg Gynecol Obstet; 1969 Sep; 129(3):556-64. PubMed ID: 5387698 [No Abstract] [Full Text] [Related]
19. [Effect of a neuroleptic, haloperidol, on the gestation and prenatal development of rodents. Results of 3 groups of experiments]. Bertelli A; Polani PE; Spector R; Seller MJ; Tuchmann-Duplessis H; Mercier-Parot L Arzneimittelforschung; 1968 Nov; 18(11):1420-4. PubMed ID: 5755906 [No Abstract] [Full Text] [Related]
20. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]